SMTL ID : 6x3o.2 (1 other biounit)

Co-structure of BTK kinase domain with L-005191930 inhibitor

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 1.90 Å
Oligo State
monomer
Ligands
1 x ULY: 4-{8-amino-3-[(6R,8aS)-3-oxo-3,5,6,7,8,8a-hexahydroindolizin-6-yl]imidazo[1,5-a]pyrazin-1-yl}-3-methoxy-N-[4-(trifluoromethyl)pyridin-2-yl]benzamide(Non-covalent)
1 x 5WE: 4-[8-azanyl-3-[(2~{S})-1-[4-(dimethylamino)butanoyl]pyrrolidin-2-yl]imidazo[1,5-a]pyrazin-1-yl]-~{N}-(1,3-thiazol-2-yl)benzamide(Non-covalent)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Liu, J. et al., Potent, non-covalent reversible BTK inhibitors with 8-amino-imidazo[1,5-a]pyrazine core featuring 3-position bicyclic ring substitutes. Bioorg.Med.Chem.Lett. (2020)
Release Date
2020-07-22
Peptides
Tyrosine-protein kinase BTK: A
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
B

Tyrosine-protein kinase BTK

Related Entries With Identical Sequence

5fbn.1 | 5fbn.2 | 5fbo.1 | 5u9d.1 | 5vfi.1 | 6di0.1 | 6di1.1 | 6di3.1 | 6di5.1 | 6di9.1 | 6n9p.1 | 6nfh.1 | 6omu.1 | 6x3n.1 | 6x3o.1 | 6x3p.1 | 7kxm.1 | 7kxp.1 | 7l5o.1 | 7l5p.1 | 7l5p.2 | 7r60.1 | 8e2m.1